Molnupiravir
- CAS No.
- 2492423-29-5
- Chemical Name:
- Molnupiravir
- Synonyms
- [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate;Mona Bilavi;Monopiravir;Molnupiravir RS;Molnupiravir-IHS/IP;Molnupiravir-001-QA;Molnupiravir In-House;Molnupiravir, 10 mM in DMSO;Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-;Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-
- CBNumber:
- CB08369543
- Molecular Formula:
- C13H19N3O7
- Molecular Weight:
- 329.31
- MDL Number:
- MFCD32663515
- MOL File:
- 2492423-29-5.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Density | 1.62±0.1 g/cm3(Predicted) |
|---|---|
| storage temp. | Store at -20°C |
| solubility | DMSO : 100 mg/mL (303.67 mM; Need ultrasonic) |
| pka | 6.71±0.20(Predicted) |
| form | Solid |
| color | White to off-white |
| InChI | InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1 |
| InChIKey | HTNPEHXGEKVIHG-QCNRFFRDSA-N |
| SMILES | C(OC(=O)C(C)C)[C@H]1O[C@@H](N2C=C/C(=N/O)/NC2=O)[C@H](O)[C@@H]1O |
| FDA UNII | YA84KI1VEW |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() ![]() GHS02,GHS07 |
|---|---|
| Signal word | Danger |
| Hazard statements | H315-H319-H228 |
| Precautionary statements | P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
Molnupiravir price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 29586 | Molnupiravir ≥98% | 2492423-29-5 | 1mg | $40 | 2026-04-30 | Buy |
| Cayman Chemical | 29586 | Molnupiravir ≥98% | 2492423-29-5 | 5mg | $96 | 2026-04-30 | Buy |
| Cayman Chemical | 29586 | Molnupiravir ≥98% | 2492423-29-5 | 10mg | $171 | 2026-04-30 | Buy |
| Cayman Chemical | 29586 | Molnupiravir ≥98% | 2492423-29-5 | 25mg | $329 | 2026-04-30 | Buy |
| Cayman Chemical | 29586 | Molnupiravir ≥98% | 2492423-29-5 | 1 mg | $36 | 2024-03-01 | Buy |
Molnupiravir Chemical Properties, Uses, Production
Uses
Molnupiravir, also known as EIDD-2801/MK4482, is a ribonucleoside analog that can inhibit the replication of various RNA viruses.
Description
Prodrug of antiviral nucleoside analog; inhibits SARS-CoV, SARS-CoV-2 and MERS-CoV infection.
Definition
ChEBI: Molnupiravir is a nucleoside analogue that is N(4)-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N(4)-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19. It has a role as a prodrug, an anticoronaviral agent and an antiviral drug. It is a nucleoside analogue, an isopropyl ester and a ketoxime. It is functionally related to a N(4)-hydroxycytidine.
Biological Activity
Molnupiravir is a broad-spectrum antiviral prodrug of the nucleoside analog β-D-N4-hydroxycytidine (NHC). It competes predominantly with CTP for incorporation; it induces lethal viral mutagenesis by increasing G to A and C to U transition mutations without inhibition of RNA synthesis in replicating coronaviruses, which prevents the development of viral resistance. In primary airway epithelial cell cultures, Molnupiravir dose-dependently inhibits SARS-CoV-2 infectious virus production; it also inhibits MERS-CoV and SARS-CoV with EC50 values in the submicromolar range. In mice infected with SARS-CoV or MERS-CoV, it improves pulmonary function, and reduces virus titer and body weight loss. Molnupiravir also displays in vivo efficacy against seasonal and pandemic influenza A shed virus. It is orally bioavailable.
storage
Store at -20°C
Molnupiravir Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Changsha Fuzhen Biotechnology Co.,LTD | 15111215862 18229892877 | 3062105966@qq.com | China | 5568 | 58 |
| Jinan Chenghui Shuangda biological Co., LTD | 053158897070 15550412551 | market@jnchsd.com | China | 224 | 62 |
| Bide Pharmatech Ltd. | 400-164-7117 18317119277 | product02@bidepharm.com | China | 40000 | 60 |
| Chengdu DingDang Pharmaceutical Co., Ltd. | 028-86040038 | market@dingdangchem.com | China | 1853 | 55 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| Hubei widely chemical technology Co., Ltd. | 17771478861 13419635609 | 3525818213@qq.com | China | 1887 | 55 |
| AnHui HaiKang Pharmaceutical Co., Ltd. | 86-0556-5800026 17709662922 | wangyu@hkpharm.cn | China | 281 | 55 |
| CHENGHUI PHARMACEUTICAL GROUP LTD | 053158897070 15550412551 | market@jnchsd.com | China | 241 | 58 |
| Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. | 0531-58897130 15508676053 | drug_impurity@sdcclh.com | China | 2526 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
View Latest Price from Molnupiravir manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-09-17 | Molnupiravir
2492423-29-5
|
$1.00 | 300g | 99.8% | 20 TONS | .GZ HONESTCHEM CO.,LTD | |
![]() |
2026-08-20 | Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-
2492423-29-5
|
$1.10 | 1g | 99.9% Min | 100 Tons | Dideu Industries Group Limited | |
![]() |
2026-07-28 | Molnupiravir
2492423-29-5
|
99.98% | 10g | TargetMol Chemicals Inc. |
-

- Molnupiravir
2492423-29-5
- $1.00
- 99.8%
- .GZ HONESTCHEM CO.,LTD
-

- Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-
2492423-29-5
- $1.10
- 99.9% Min
- Dideu Industries Group Limited
-

- Molnupiravir
2492423-29-5
- $0.00
- 99.98%
- TargetMol Chemicals Inc.






